drugset / Trial / NCT00517426

Effects of Acetazolamide and CO2 Inhalation on Exercise-induced Periodic Breathing in Heart Failure

NCT00517426

Phase 4 Completed 20 enrolled Centro Cardiologico Monzino
NaSingle-groupOpen-label

Summary

To evaluate the effects of CO2 inhalation and acetazolamide treatment on exercise-induced periodic breathing in patients with chronic stable heart failure. Patients will be given CO2 (2%) during a constant workload exercise. Patients will be also evaluated by maximal cardiopulmonary exercise test without and with acetazolamide acute and chronic treatment.

Timeline

Start
2007-07
Primary completion
2011-07
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetazolamide Small molecule 500 mg Intravenous

Indications